SYMBIOTEC — Symbiotec Pharmalab Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapHigh Flyer

Annual balance sheet for Symbiotec Pharmalab, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	86.9	137	310	307
Net Total Accounts Receivable
Net Total Receivables	1,411	1,452	1,882	2,055
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4,002	5,082	4,929	4,855
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4,807	6,195	9,697	11,489
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	9,900	12,948	15,797	17,808
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,281	3,512	4,726	5,276
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	3,685	5,797	7,648	6,311
Common Stock
Other Equity
Total Equity	6,215	7,150	8,149	11,497
Total Liabilities & Shareholders' Equity	9,900	12,948	15,797	17,808
Total Common Shares Outstanding